Datar Cancer Genetics (Europe) GmbH

Datar Cancer Genetics (Europe) GmbH is a company in Eckersdorf, Germany that has taken part in 1 EU-funded project since 2020, receiving €101k in EU funding.

EU funding received€101k
EU projects1
As coordinator0
Running now0
First EU project2020
Latest project2020
CountryGermany
EU registration (PIC)901346311
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Datar Cancer Genetics (Europe) GmbH's own share of each project, not the project's full budget.

  • Horizon 2020€101k · 1 project

Projects

1 EU-funded project, newest first. Each links to the official record.

  • PRISAR2Partner

    proactive monitoring of cancer as an alternative to surgery

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €101ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • oncology
  • radiation chemistry
  • surgical procedures

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime